Elsbernd Brian's Form 4 filing
Catalyst Pharmaceuticals, Inc. (CPRX) · filed Nov 29, 2024
- Accession no.
- 0001161697-24-000490
- Filed
- Nov 29, 2024
- Trade date
- Nov 26, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $286.7K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Elsbernd BrianCIK 0001763511 | Officer (Chief Compliance/Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 26, 2024 | Common Stock, par value $0.001 per share | MOption exerciseAcquired | +50,244 | $4.01 | +$201,478.44 | 174,677 | Direct | |
| Nov 26, 2024 | Common Stock, par value $0.001 per share | SSaleDisposed | −9,300 | $21.65 | −$201,345 | 165,377 | Direct | |
| Nov 26, 2024 | Common Stock, par value $0.001 per share | MOption exerciseAcquired | +9,756 | $4.01 | +$39,121.56 | 175,133 | Direct | |
| Nov 26, 2024 | Common Stock, par value $0.001 per share | SSaleDisposed | −3,956 | $21.58 | −$85,370.48 | 171,177 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 26, 2024 | Common Stock | MOption exerciseDisposed | −50,244 | $0.00 | $0 | 1,104,766 | Direct | |
| Nov 26, 2024 | Common Stock | MOption exerciseDisposed | −9,756 | $0.00 | $0 | 1,095,010 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.